HIV Infections and AIDS
exp date isn't null, but text field is
Acquired Immune Deficiency Syndrome (AIDS) is a late stage of infection with the Human Immune Deficiency Virus (HIV). It can affect both adults and children often predisposing them to opportunistic infections and certain malignancies. Co-infection with tuberculosis (TB) and Hepatitis B are particularly frequent in HIV infected individuals and must be screened for in all cases.
The main risk factors for HIV/AIDS remain transmission by exchange of body fluids and blood products through sexual contact, transfusion, needle-stick injury, non-sterile surgical practices and mother to child transfer.
HIV infection is currently not curable. However, for persons living with HIV infection (PLHIV), effective anti-retroviral therapy (ART) is available country-wide at accredited centres at the regional and district level in both public and private health care facilities to which all diagnosed patients must be referred.
Prevention of infection remains the key to reducing its spread.
Cause
- Human Immunodeficiency Virus
Symptoms
- Persistent cough
- Persistent or recurrent diarrhoea
- Weight loss
- Skin rashes
- Persistent or recurrent fever
- Mouth ulcers
Signs
- Weight loss
- Chronic diarrhoea
- Prolonged fever
- Generalised lymphadenopathy
- Oropharyngeal candidiasis
- Persistent cough
- Generalised dermatitis
- Recurrent herpes zoster (adults)
- Chronic progressive and disseminated herpes simplex infections (adults)
- Finger nail changes e.g. blue discoloration of the nails (adults)
- Failure to thrive or slow growth (infants and children)
- Recurrent common infections e.g. otitis media, pharyngitis (infants and children)
Investigations
- Confirmatory HIV test (HIV1, HIV2, HIV1 and 2)
- HIV Viral load
- CD4 count
- Other tests as required (See Table below)
Other baseline tests for HIV |
|
Haematological test |
Full blood count |
Biochemical test |
Blood Urea Electrolytes and Creatinine Liver Function tests Fasting Blood Sugar Cholesterol and lipid profile |
Routine examinations |
Urinalysis (Urine R/E) Stool R/E |
Respiratory examinations |
TB screening Chest X-ray |
Serological Test |
Serological Test Hepatitis B Surface antigen |
Supplementary tests |
Histology on skin and lymph node biopsy Kidney biopsy Screening for STIs Pregnancy test Pap smear, HPV DNA |
TreatmentTreatment Objectives
- To suppress HIV replication to as low as possible and for as long as possible
- To preserve and enhance the immune function (CD4 restoration)
- To improve quality of life
- To reduce morbidity and mortality related to HIV
- To promote growth and neurological development in children
Pharmacological treatment Standard Treatment
1st Line Treatment
Standard Treatment (1st Line Treatment) for HIV-AIDS |
||
Medicines |
Caution |
Comment |
Preferred Regimen |
||
Tenofovir (TDF) + Lamivudine (3TC) (or Emtricitabine) + Efavirenz (EFV) |
Caution with |
Monitor renal function including urinalysis |
Alternative Regimen |
||
Tenofovir + Lamivudine (or Emtricitabine (FTC)) + Nevirapine (NVP) |
Caution with |
Monitor renal function including urinalysis Stop NVP if client develops jaundice or severe rashes and refer to ART centre for further management. |
Zidovudine (AZT) + Lamivudine (3TC) + Nevirapine (NVP) |
Zidovudine is |
TDF to be used where Hb is < 8 g/dL or drops >25% from the baseline value in a client on AZT. Stop NVP if client develops jaundice or severe rashes and refer to ART centre for further management |
Zidovudine (AZT) + Lamivudine (3TC) + Efavirenz (EFV) |
Zidovudine is |
TDF to be used where Hb is < 8 g/dL or drops >25% from the baseline value in a client on AZT. |
2nd Line Treatment
Standard Treatment (2nd Line Treatment) for HIV-AIDS |
||
|
Medicines |
Comments |
First Alternative |
Zidovudine + Lamivudine (or Emtricitabine) + Lopinavir/r (or |
If TDF based first line. If LPV/r was used for HIV2 in first line, use ATV/r |
Second Alternative |
Tenofovir + Lamivudine (or Emtricitabine) + Lopinavir/r (or Atazanavir/r) |
If ZDV based first line. Consider Abacavir if patient has used both Tenofovir and Zidovudine |
Special conditions
Standard Treatment in special conditions for HIV-AIDS |
||
Condition |
Recommendation |
Comments |
HIV co-infection with Hepatitis B. (See section on ‘Hepatitis B’) |
The recommended regimen shall be: Lamivudine + Tenofovir + Efavirenz |
Lamivudine and Tenofovir are active against both HBV and HIV |
Dual HIV-1 and HIV-2 or HIV-2 infections |
Due to the ineffectiveness of non-nucleoside drugs (Nevirapine and Efavirenz) in HIV-2 infection combination of nucleosides and protease inhibitors such as LPVr or ATV/r should be used. |
|
Referral Criteria
- Refer all HIV positive patients to an accredited treatment centre in Ghana.